{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T14:47:23Z","timestamp":1785422843624,"version":"3.56.0"},"reference-count":57,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T00:00:00Z","timestamp":1784592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["405618\/2025-5"],"award-info":[{"award-number":["405618\/2025-5"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"award":["405618\/2025-5"],"award-info":[{"award-number":["405618\/2025-5"]}],"id":[{"id":"https:\/\/ror.org\/03swz6y49","id-type":"ROR","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005668","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Distrito Federal","doi-asserted-by":"publisher","award":["00193-00002417\/2023-55"],"award-info":[{"award-number":["00193-00002417\/2023-55"]}],"id":[{"id":"10.13039\/501100005668","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>SETD5 (SET domain-containing 5) is a chromatin-associated regulator increasingly recognized as dysregulated in human malignancies; however, its contribution to tumor biology and tumor\u2013immune interactions remain undefined. We performed an integrative pan-cancer multi-omics analysis to define the landscape of SETD5 dysregulation across cancer types. Transcriptomic, genomic, and epigenetic datasets were integrated to evaluate SETD5 alterations and molecular associations. Protein interaction and pathway enrichment analyses were conducted using STRING, GO, and KEGG, and immunogenomic profiling was used to interrogate associations between SETD5 expression, immune infiltration, and checkpoint programs. SETD5 was overexpressed across multiple malignancies, with low mutation frequency but recurrent copy-number gains. Promoter hypomethylation was detected in a subset of tumors with increased SETD5 expression, suggesting a possible association with epigenetic regulation. Pathway analyses linked SETD5 to macromolecule methylation and transcriptional regulation. SETD5 expression correlated positively with infiltration of macrophages, neutrophils, and dendritic cells, whereas associations with CD8+ and CD4+ T cells varied by tumor type. Tumor type-specific correlations were observed between SETD5 and immune checkpoints genes, including PD-L1 and TIM-3, suggesting an association with immunoregulatory tumor states. These findings identify SETD5 as a recurrently deregulated epigenetic regulator and highlight its potential role in transcriptional control and tumor immune modulation.<\/jats:p>","DOI":"10.3390\/cimb48070742","type":"journal-article","created":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T10:35:52Z","timestamp":1784630152000},"page":"742","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative Analysis Uncovers SETD5 as an Epigenetic Regulator of Transcriptional and Immune Tumor Programs Across Human Cancers"],"prefix":"10.3390","volume":"48","author":[{"given":"Ana Cristina Moura","family":"Gualberto","sequence":"first","affiliation":[{"name":"Laboratory of Molecular Pathology of Cancer, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunna Let\u00edcia de Oliveira","family":"Santana","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pathology of Cancer, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7816-764X","authenticated-orcid":false,"given":"Mariana Braccialli","family":"de Loyola","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pathology of Cancer, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3759-9611","authenticated-orcid":false,"given":"Yasmim Sampaio","family":"da Costa","sequence":"additional","affiliation":[{"name":"Laboratory on Thymus Research, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil"},{"name":"National Institute of Science and Technology on Neuroimmunomodulation, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro 21040-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9644-7098","authenticated-orcid":false,"given":"F\u00e1bio","family":"Pittella-Silva","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Pathology of Cancer, Faculty of Health Sciences, University of Brasilia, Brasilia 70910-900, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,7,21]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: New dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"eaal2380","DOI":"10.1126\/science.aal2380","article-title":"Epigenetic plasticity and the hallmarks of cancer","volume":"357","author":"Flavahan","year":"2017","journal-title":"Science"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/j.cell.2017.01.017","article-title":"Primary, adaptive, and acquired resistance to cancer immunotherapy","volume":"168","author":"Sharma","year":"2017","journal-title":"Cell"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/nrg.2016.13","article-title":"Epigenetic modulators, modifiers and mediators in cancer a etiology and progression","volume":"17","author":"Feinberg","year":"2016","journal-title":"Nat. Rev. Genet."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1007\/s10528-024-10766-w","article-title":"Knockdown of SETD5 inhibits colorectal cancer cell growth and stemness by regulating PI3K\/AKT\/mTOR pathway","volume":"63","author":"Zhou","year":"2025","journal-title":"Biochem. Genet."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"33520","DOI":"10.1038\/s41598-025-17871-9","article-title":"SETD5 in glioma cells conferred TRAIL resistance induction","volume":"15","author":"Taneja","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e70076","DOI":"10.1111\/pin.70076","article-title":"High immunohistochemical expression of SETD5 as a candidate pathological factor for dedifferentiation and prognosis in liposarcoma","volume":"76","author":"Abe","year":"2025","journal-title":"Pathol. Int."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.ajpath.2021.12.006","article-title":"SETD5 regulates glycolysis in breast cancer stem-like cells and fuels tumor growth","volume":"192","author":"Yang","year":"2022","journal-title":"Am. J. Pathol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/j.ccell.2020.04.014","article-title":"SETD5-coordinated chromatin reprogramming regulates adaptive resistance to targeted pancreatic cancer therapy","volume":"37","author":"Wang","year":"2020","journal-title":"Cancer Cell"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1038\/s41388-025-03426-9","article-title":"SETD5 facilitates stemness and represses ferroptosis via m6A-mediating PKM2 stabilization in non-small cell lung cancer","volume":"44","author":"Liu","year":"2025","journal-title":"Oncogene"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Li, M., Hou, Y., Zhang, Z., Zhang, B., Huang, T., Sun, A., Shao, G., and Lin, Q. (2023). Structure, activity and function of the lysine methyltransferase SETD5. Front. Endocrinol., 14.","DOI":"10.3389\/fendo.2023.1089527"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"15330338221090090","DOI":"10.1177\/15330338221090090","article-title":"CircRNA PTPRM promotes non-small cell lung cancer progression by modulating the miR-139-5p\/SETD5 axis","volume":"21","author":"Jiang","year":"2022","journal-title":"Technol. Cancer Res. Treat."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/cvr\/cvu040","article-title":"miR126-5p repression of ALCAM and SetD5 in endothelial cells regulates leucocyte adhesion and transmigration","volume":"102","author":"Poissonnier","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1089\/omi.2011.0118","article-title":"clusterProfiler: An R package for comparing biological themes among gene clusters","volume":"16","author":"Yu","year":"2012","journal-title":"Omics"},{"key":"ref_16","first-page":"1803","article-title":"SETDB1 in cancer: Overexpression and its therapeutic implications","volume":"11","author":"Salari","year":"2021","journal-title":"Am. J. Cancer Res."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1038\/s12276-024-01326-8","article-title":"SMYD family in cancer: Epigenetic regulation and molecular mechanisms of cancer proliferation, metastasis, and drug resistance","volume":"56","author":"Han","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nature11606","article-title":"EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutations","volume":"492","author":"McCabe","year":"2012","journal-title":"Nature"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/nrd2974","article-title":"Protein methyltransferases as a target class for drug discovery","volume":"8","author":"Copeland","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1186\/s12967-025-06908-2","article-title":"Distinctive chromosomal, mutational and transcriptional profiling in colon versus rectal cancers","volume":"23","author":"Rizzuto","year":"2025","journal-title":"J. Transl. Med."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Zengin, T., and \u00d6nal-S\u00fczek, T. (2021). Comprehensive profiling of genomic and transcriptomic differences between risk groups of lung adenocarcinoma and lung squamous cell carcinoma. J. Pers. Med., 11.","DOI":"10.1101\/2020.12.31.424952"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1038\/nature08822","article-title":"The landscape of somatic copy-number alteration across human cancers","volume":"463","author":"Beroukhim","year":"2010","journal-title":"Nature"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/ng.2760","article-title":"Pan-cancer patterns of somatic copy number alteration","volume":"45","author":"Zack","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.canlet.2017.03.029","article-title":"Oncogenic roles of DNA hypomethylation through the activation of cancer-germline genes","volume":"396","author":"Loriot","year":"2017","journal-title":"Cancer Lett."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.trecan.2020.02.007","article-title":"Promoter DNA hypermethylation and paradoxical gene activation","volume":"6","author":"Smith","year":"2020","journal-title":"Trends Cancer"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"3982226","DOI":"10.1155\/2022\/3982226","article-title":"A pan-cancer study of KMT2 family as therapeutic targets in cancer","volume":"2022","author":"Zhu","year":"2022","journal-title":"J. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.humpath.2022.12.001","article-title":"Clinical and histopathologic characterization of SETD2-mutated colorectal cancer","volume":"131","author":"Bushara","year":"2023","journal-title":"Hum. Pathol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e70126","DOI":"10.1002\/iid3.70126","article-title":"Identification of SETD4 as an onco-immunological biomarker encompassing the tumor microenvironment, prognoses, and therapeutic responses in various human cancers","volume":"13","author":"Zhong","year":"2025","journal-title":"Immun. Inflamm. Dis."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"11900","DOI":"10.1093\/nar\/gkab927","article-title":"THUMPD3-TRMT112 is a m2G methyltransferase working on a broad range of tRNA substrates","volume":"49","author":"Yang","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"7496","DOI":"10.1093\/nar\/gkad487","article-title":"N2-methylguanosine modifications on human tRNAs and snRNA U6 are important for cell proliferation, protein translation and pre-mRNA splicing","volume":"51","author":"Wang","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ejhg.2014.165","article-title":"Loss-of-function variants of SETD5 cause intellectual disability and the core phenotype of microdeletion 3p25.3 syndrome","volume":"23","author":"Kuechler","year":"2015","journal-title":"Eur. J. Hum. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"eadn1397","DOI":"10.1126\/sciadv.adn1397","article-title":"Chrom-seq identifies RNAs at chromatin marks","volume":"10","author":"Fan","year":"2024","journal-title":"Sci. Adv."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"112699","DOI":"10.1016\/j.isci.2025.112699","article-title":"KBG syndrome-associated protein ANKRD11 regulates SETD5 expression to modulate rRNA levels and translation","volume":"28","author":"Sashiyama","year":"2025","journal-title":"iScience"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.molcel.2012.11.006","article-title":"Histone lysine methylation dynamics: Establishment, regulation, and biological impact","volume":"48","author":"Black","year":"2012","journal-title":"Mol. Cell."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nrg3173","article-title":"Histone methylation: A dynamic mark in health, disease and inheritance","volume":"13","author":"Greer","year":"2012","journal-title":"Nat. Rev. Genet."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1146\/annurev-genet-110711-155440","article-title":"Control of transcriptional elongation","volume":"47","author":"Kwak","year":"2013","journal-title":"Annu. Rev. Genet."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/nrm3953","article-title":"Getting up to speed with transcription elongation by RNA polymerase II","volume":"16","author":"Jonkers","year":"2015","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"2470","DOI":"10.1016\/j.gendis.2022.10.028","article-title":"Lysine succinylation, the metabolic bridge between cancer and immunity","volume":"10","author":"Shen","year":"2022","journal-title":"Genes Dis."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"6574","DOI":"10.1038\/s41598-024-56831-7","article-title":"CDK12 is a potential biomarker for diagnosis, prognosis and immunomodulation in pan-cancer","volume":"14","author":"Lu","year":"2024","journal-title":"Sci. Rep."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"20220697","DOI":"10.1515\/biol-2022-0697","article-title":"Knockdown of SETD5 inhibited glycolysis and tumor growth in gastric cancer cells by down-regulating Akt signaling pathway","volume":"18","author":"Shi","year":"2023","journal-title":"Open Life Sci."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"550","DOI":"10.14348\/molcells.2022.0009","article-title":"Downregulation of SETD5 suppresses the tumorigenicity of hepatocellular carcinoma cells","volume":"45","author":"Park","year":"2022","journal-title":"Mol. Cells"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev-immunol-041015-055318","article-title":"CD8 T cell exhaustion during chronic viral infection and cancer","volume":"37","author":"McLane","year":"2019","journal-title":"Annu. Rev. Immunol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.20100637","article-title":"Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients","volume":"207","author":"Fourcade","year":"2010","journal-title":"J. Exp. Med."},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Zang, K., Hui, L., Wang, M., Huang, Y., Zhu, X., and Yao, B. (2021). TIM-3 as a prognostic marker and a potential immunotherapy target in human malignant tumors: A meta-analysis and bioinformatics validation. Front. Oncol., 11.","DOI":"10.3389\/fonc.2021.579351"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/prm2.12007","article-title":"Prognostic and clinicopathological value of high expression of TIM-3 in different cancer types: A meta-analysis","volume":"9","author":"Xu","year":"2020","journal-title":"Precis. Med. Sci."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1158\/0008-5472.CAN-16-0274","article-title":"Tim-3 expression on tumor-infiltrating PD-1+CD8+ T cells correlates with poor clinical outcome in renal cell carcinoma","volume":"77","author":"Granier","year":"2017","journal-title":"Cancer Res."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1084\/jem.20082173","article-title":"Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1","volume":"206","author":"Kuang","year":"2009","journal-title":"J. Exp. Med."},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Pan, Y., Yu, Y., Wang, X., and Zhang, T. (2020). Tumor-associated macrophages in tumor immunity. Front. Immunol., 11.","DOI":"10.3389\/fimmu.2020.583084"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1084\/jem.20111413","article-title":"Ovarian cancer progression is controlled by phenotypic changes in dendritic cells","volume":"209","author":"Scarlett","year":"2012","journal-title":"J. Exp. Med."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.coi.2017.01.002","article-title":"Dendritic cells in cancer: The role revisited","volume":"45","author":"Veglia","year":"2017","journal-title":"Curr. Opin. Immunol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"e192535","DOI":"10.1001\/jamanetworkopen.2019.2535","article-title":"Estimation of the percentage of US patients with cancer who are eligible for and respond to checkpoint inhibitor immunotherapy drugs","volume":"2","author":"Haslam","year":"2019","journal-title":"JAMA Netw. Open"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"10501","DOI":"10.1038\/ncomms10501","article-title":"Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints","volume":"7","author":"Koyama","year":"2016","journal-title":"Nat. Commun."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/7\/742\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T11:23:40Z","timestamp":1784633020000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/48\/7\/742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,21]]},"references-count":57,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["cimb48070742"],"URL":"https:\/\/doi.org\/10.3390\/cimb48070742","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,21]]}}}